Previtera, F.; Restaino, S.; Romano, G.; Vizzielli, G.; Neri, A.; Scalzotto, E.; Vetrugno, L.; Montessoro, B.; Mioni, R.; Driul, L.
Gene Polymorphism in Five Target Genes of Immunosuppressive Therapy and Risk of Development of Preeclampsia. Healthcare 2021, 9, 821.
https://doi.org/10.3390/healthcare9070821
AMA Style
Previtera F, Restaino S, Romano G, Vizzielli G, Neri A, Scalzotto E, Vetrugno L, Montessoro B, Mioni R, Driul L.
Gene Polymorphism in Five Target Genes of Immunosuppressive Therapy and Risk of Development of Preeclampsia. Healthcare. 2021; 9(7):821.
https://doi.org/10.3390/healthcare9070821
Chicago/Turabian Style
Previtera, Francesca, Stefano Restaino, Giulio Romano, Giuseppe Vizzielli, Andrea Neri, Elisa Scalzotto, Luigi Vetrugno, Beatrice Montessoro, Roberto Mioni, and Lorenza Driul.
2021. "Gene Polymorphism in Five Target Genes of Immunosuppressive Therapy and Risk of Development of Preeclampsia" Healthcare 9, no. 7: 821.
https://doi.org/10.3390/healthcare9070821
APA Style
Previtera, F., Restaino, S., Romano, G., Vizzielli, G., Neri, A., Scalzotto, E., Vetrugno, L., Montessoro, B., Mioni, R., & Driul, L.
(2021). Gene Polymorphism in Five Target Genes of Immunosuppressive Therapy and Risk of Development of Preeclampsia. Healthcare, 9(7), 821.
https://doi.org/10.3390/healthcare9070821